| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.56B | 2.12B | 3.09B | 2.44B | 3.87B | 3.20B |
| Gross Profit | 783.00M | 764.00M | 1.21B | 165.00M | 1.42B | 1.23B |
| EBITDA | 112.00M | 98.00M | 1.11B | -1.10B | 262.00M | 995.00M |
| Net Income | 77.00M | -47.00M | 400.00M | -1.70B | -295.00M | 19.00M |
Balance Sheet | ||||||
| Total Assets | 15.24B | 21.02B | 15.42B | 16.80B | 18.77B | 20.23B |
| Cash, Cash Equivalents and Short-Term Investments | 3.70B | 4.12B | 4.30B | 2.54B | 3.13B | 5.67B |
| Total Debt | 7.21B | 10.22B | 7.42B | 9.83B | 8.99B | 9.52B |
| Total Liabilities | 8.04B | 11.39B | 8.26B | 10.66B | 9.67B | 10.79B |
| Stockholders Equity | 6.86B | 7.54B | 6.82B | 5.57B | 7.61B | 7.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 0.00 | 1.43B | 456.00M | 157.00M | -151.00M |
| Operating Cash Flow | 0.00 | -296.00M | 1.43B | 456.00M | 157.00M | -145.00M |
| Investing Cash Flow | 0.00 | -246.00M | 24.00M | -2.00M | 0.00 | 212.00M |
| Financing Cash Flow | 0.00 | -71.00M | 179.00M | -828.00M | -806.00M | -1.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥67.54B | 9.70 | 17.21% | 4.27% | 13.39% | 22.06% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥120.28B | 18.28 | 5.11% | 5.07% | -26.93% | -29.39% | |
44 Neutral | ¥20.56B | -17.28 | ― | 1.85% | -17.48% | -207.17% | |
43 Neutral | ¥15.88B | -11.91 | ― | ― | 180.01% | 33.62% | |
42 Neutral | ¥4.05B | -76.76 | 4.15% | ― | -31.54% | -110.01% |